Neurofilament-Light, a Promising Biomarker: Analytical, Metrological and Clinical Challenges - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue International Journal of Molecular Sciences Année : 2023

Neurofilament-Light, a Promising Biomarker: Analytical, Metrological and Clinical Challenges

Résumé

Neurofilament-light chain (Nf-L) is a non-specific early-stage biomarker widely studied in the context of neurodegenerative diseases (NDD) and traumatic brain injuries (TBI), which can be measured in biofluids after axonal damage. Originally measured by enzyme-linked immunosorbent assay (ELISA) in cerebrospinal fluid (CSF), Nf-L can now be quantified in blood with the emergence of ultrasensitive assays. However, to ensure successful clinical implementation, reliable clinical thresholds and reference measurement procedures (RMP) should be developed. This includes establishing and distributing certified reference materials (CRM). As a result of the complexity of Nf-L and the number of circulating forms, a clear definition of what is measured when immunoassays are used is also critical to achieving standardization to ensure the long-term success of those assays. The use of powerful tools such as mass spectrometry for developing RMP and defining the measurand is ongoing. Here, we summarize the current methods in use for quantification of Nf-L in biofluid showing potential for clinical implementation. The progress and challenges in developing RMP and defining the measurand for Nf-L standardization of diagnostic tests are addressed. Finally, we discuss the impact of pathophysiological factors on Nf-L levels and the establishment of a clinical cut-off.
Fichier principal
Vignette du fichier
ijms-24-11624.pdf (1.08 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte
Licence

Dates et versions

hal-04595869 , version 1 (31-05-2024)

Licence

Identifiants

Citer

Salomé Coppens, Sylvain Lehmann, Christopher Hopley, Christophe Hirtz. Neurofilament-Light, a Promising Biomarker: Analytical, Metrological and Clinical Challenges. International Journal of Molecular Sciences, 2023, 24 (14), pp.11624. ⟨10.3390/ijms241411624⟩. ⟨hal-04595869⟩
4 Consultations
13 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More